Amedisys Inc (AMED)

Gross profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Gross profit	US$ in thousands	1,017,680	990,873	962,774	980,756	886,150
Revenue	US$ in thousands	2,348,320	2,236,380	2,223,200	2,214,110	2,071,520
Gross profit margin		43.34%	44.31%	43.31%	44.30%	42.78%

December 31, 2024 calculation

Gross profit margin = Gross profit ÷ Revenue
= $1,017,680K ÷ $2,348,320K
= 43.34%

Amedisys Inc's gross profit margin has shown a generally positive trend over the years based on the provided data. It increased from 42.78% as of December 31, 2020, to 44.30% as of December 31, 2021, indicating an improvement in the company's ability to generate profits from its core operations.

Subsequently, the gross profit margin continued to oscillate within a relatively narrow range, reaching 43.31% by December 31, 2022, and further increasing to 44.31% by December 31, 2023. This suggests a stable performance in managing its cost of goods sold and enhancing profitability during these periods.

However, by December 31, 2024, the gross profit margin slightly decreased to 43.34%. This dip may indicate potential challenges in maintaining or improving profit margins, which could be attributed to various factors such as changes in pricing strategies, input costs, or operational inefficiencies.

Overall, Amedisys Inc's trend in gross profit margin reflects a generally positive performance with some fluctuations, emphasizing the importance of monitoring and addressing the key drivers affecting profitability to sustain financial health and competitiveness in the industry.